Document Detail

Fluorodeoxyuridine mediated cell cycle synchronization in S-phase increases the Auger radiation cell killing with 125I-iododeoxyuridine.
MedLine Citation:
PMID:  19795077     Owner:  NLM     Status:  In-Data-Review    
Aim: 125I-iododeoxyuridine is a potential Auger radiation therapy agent. Its incorporation in DNA of proliferating cells is enhanced by fluorodeoxyuridine. Here, we evaluated therapeutic activities of 125I-iododeoxyuridine in an optimized fluorodeoxyuridine pre-treatment inducing S-phase synchronization. Methods: After S-phase synchronization by fluorodeoxyuridine, cells were treated with 125I-iododeoxyuridine. Apoptosis analysis and S-phase synchronization were studied by flow cytometry. Cell survival was determined by colony-forming assay. Based on measured growth parameters, the number of decays per cell that induced killing was extrapolated. Results: Treatment experiments showed that 72 to 91% of synchronized cells were killed after 0.8 and 8 kBq/ml 125I-iododeoxyuridine incubation, respectively. In controls, only 8 to 38% of cells were killed by corresponding 125I-iododeoxyuridine activities alone and even increasing the activity to 80 kBq/ml gave only 42 % killing. Duplicated treatment cycles or repeated fluorodeoxyuridine pre-treatment allowed enhancing cell killing to >95 % at 8 kBq/ml 125I-iododeoxyuridine. About 50 and 160 decays per S-phase cells in controls and S-phase synchronization, respectively, were responsible for the observed cell killing at 0.8 kBq/ml radio-iododeoxyuridine. Conclusion: These data show the successful application of fluorodeoxyuridine that provided increased 125I-iododeoxyuridine Auger radiation cell killing efficacy through S-phase synchronization and high DNA incorporation of radio-iododeoxyuridine.
F Perillo-Adamer; M Kosinski; Y M Dupertuis; D Viertl; A Bischof Delaloye; F Buchegger
Related Documents :
9202647 - Cucurbitacin e targets proliferating endothelia.
19259937 - Dna damage mediated s and g(2) checkpoints in human embryonal carcinoma cells.
7882457 - Synchronization of cells in the s phase of the cell cycle by 3'-azido-3'-deoxythymidine...
9673417 - 2-deoxy-d-[1-3h]glucose uptake by mcf7 and t47d breast tumour cells under conditions of...
9440337 - A dynamic model of outer hair cell motility including intracellular and extracellular f...
11420687 - Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast c...
Publication Detail:
Type:  Journal Article     Date:  2009-10-01
Journal Detail:
Title:  Nuklearmedizin. Nuclear medicine     Volume:  48     ISSN:  0029-5566     ISO Abbreviation:  Nuklearmedizin     Publication Date:  2009  
Date Detail:
Created Date:  2009-12-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7609387     Medline TA:  Nuklearmedizin     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  233-42     Citation Subset:  IM    
Franz Buchegger, Service of Nuclear Medicine, University Hospital, Rue du Bugnon 46, 1011 Lausanne, SwitzerlandTel. +41/21/314 43 73, Fax +41/21/314 43 49 E-mail:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nucleosome positioning--what do we really know?
Next Document:  Distal pancreatectomy with en bloc resection of the celiac axis for pancreatic adenocarcinoma.